US FDA Still Seeking Sponsor Cooperation For Oncology Label Updates

Bladder cancer
Labeling for cisplatin, a treatment for bladder cancer, also is under review as part of Project Renewal. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Generics

More from Biosimilars & Generics